StockNews.com began coverage on shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Free Report) in a research report released on Friday. The firm issued a sell rating on the stock. Several other brokerages have also recently weighed in on ZYNE. HC Wainwright cut Zynerba Pharmaceuticals from a buy rating to a neutral rating in a report on […]
Bernardo Wealth Planning LLC boosted its stake in shares of Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE – Free Report) by 103.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 78,578 shares of the company’s stock after acquiring an additional 40,000 shares during the […]
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE – Get Free Report) President Terri B. Sebree sold 12,401 shares of the company’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $1.33, for a total value of $16,493.33. Following the completion of the transaction, the president now directly owns 596,241 shares […]
Zynerba Pharmaceuticals (NASDAQ:ZYNE) Now Covered by Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Zynerba Pharmaceuticals (NASDAQ:ZYNE) Rating Lowered to Neutral at LADENBURG THALM/SH SH kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.